CellWell record HH-205329
1-year patient-reported outcomes in patients with a documented GLP-1 agonist prescription history prior to total hip arthroplasty: a retrospective cohort study
Brian Benyamini; Shujaa T Khan; Khaled A Elmenawi; Shlok V Patel; Matthew E Deren; Nicolas S Piuzzi
2026
In plain language
Patients with GLP-1 agonist prescription history showed reduced 90-day readmission but increased 90-day medical complications after total hip arthroplasty; no difference in 1-year functional outcomes.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-205329
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.